Skip to content

Gilead acquires HIV integrase inhibitor from Japan Tobacco

CCR5 antagonists unlikely to aggravate hepatitis C infection, French study reports

Lipid monitoring and cholesterol management also essential for children with HIV, US study suggests

The New York resistance case: details published in The Lancet

Gilead extends access programme for tenofovir, Truvada to Central America, Caribbean

Late HIV diagnosis common in British gay men and linked to increased mortality

Adherence in depressed HIV-positive patients improved by antidepressant treatment

Immune Reconstitution Inflammatory Syndrome (IRIS) observed in almost a third of advanced patients beginning antiretroviral therapy in Texan study

Correction: Kaletra price in South Africa